TELA
Tela Bio Inc.
NASDAQ · Healthcare
| Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | |
|---|---|---|---|---|---|---|---|---|---|
| Operating | |||||||||
| Operating Cash Flow | — | — | — | — | — | — | — | — | — |
| Net Income | — | — | — | — | — | — | — | — | — |
| Depreciation & Amort. | — | — | — | — | — | — | — | — | — |
| Stock-Based Comp. | — | — | — | — | — | — | — | — | — |
| Changes in WC | — | — | — | — | — | — | — | — | — |
| Investing | |||||||||
| Capital Expenditures | 448,000 | 989,000 | 611,000 | 872,000 | 627,000 | 167,000 | 197,000 | 62,000 | 114,000 |
| Acquisitions | — | — | — | — | — | — | — | — | — |
| Investing Cash Flow | — | — | — | — | — | — | — | — | — |
| Financing | |||||||||
| Debt Repayment | — | — | — | — | — | — | — | — | — |
| Common Stock Issued | — | — | — | — | — | — | — | — | — |
| Buybacks | — | — | — | — | — | — | — | — | — |
| Dividends Paid | — | — | — | — | — | — | — | — | — |
| Financing Cash Flow | — | — | — | — | — | — | — | — | — |
| Summary | |||||||||
| Free Cash Flow | -28.7M | -42.6M | -41.5M | -41.6M | -31.1M | -24.6M | -25.7M | -20.0M | -16.5M |
| Net Change in Cash | — | — | — | — | — | — | — | — | — |